Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4608
MDCX
Medicus Pharma Ltd. - Common Stock
0.36 USD-2.70%-16.28%+12.50%-69.49%20.40 M USD
4789
APUS
Apimeds Pharmaceuticals US, Inc. Common Stock
0.74 USD0.00%-1.33%-42.19%-43.51%11.17 M USD
5029
PPCB
Propanc Biopharma, Inc. - Common Stock
1.63 USD+1.87%-7.91%-25.23%-59.25%3.71 M USD
5060
DCOY
Decoy Therapeutics Inc. - Common Stock
5.75 USD-1.54%-12.61%-8.87%+610.93%3.06 M USD

Frequently asked questions about Kairos Pharma, Ltd. Common Stock

What is the Kairos Pharma, Ltd. Common Stock stock price today?

The current price of Kairos Pharma, Ltd. Common Stock (KAPA) is 0.36. Over the past 24 hours, the stock has changed by +5.88%. Follow the KAPA chart for real-time price dynamics.

What is the stock ticker of Kairos Pharma, Ltd. Common Stock?

Kairos Pharma, Ltd. Common Stock trades under the ticker KAPA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Kairos Pharma, Ltd. Common Stock stock going up?

KAPA has changed by -2.70% over the last week, -20.00% over the last month, and -37.93% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Kairos Pharma, Ltd. Common Stock net income for the last quarter?

Kairos Pharma, Ltd. Common Stock reported net income of -1.65 M for the last quarter. The previous quarter showed -1.36 M, which means net income changed by -21.17%.

How many employees does Kairos Pharma, Ltd. Common Stock have?

As of the latest available data, Kairos Pharma, Ltd. Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Kairos Pharma, Ltd. Common Stock stock?

You can buy Kairos Pharma, Ltd. Common Stock (KAPA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Kairos Pharma, Ltd. Common Stock stock?

Investing in Kairos Pharma, Ltd. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KAPA chart and related analysis on metatrader.com as part of your research.